BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 394087)

  • 1. [Interaction of phenylbutazone and tolbutamide in man].
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Orv Hetil; 1979 Nov; 120(47):2843-4. PubMed ID: 394087
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of salicyl compounds and other non-steroidal anti-inflammatory agents: pharmacokinetic study of phenylbutazone-aspirin combination in man].
    Gaucher A; Netter P; Faure G; Tamisier JN; Pourel J; Maillard A; Royer RJ
    Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):425-9. PubMed ID: 781789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Pharmacokinetic analysis of the dicumarol-tolbutamide interaction in man.
    Jähnchen E; Gilfrich HJ; Groth U; Meinertz T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R88. PubMed ID: 49859
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Phenylbutazone-tolbutamide drug interaction.
    Tannenbaum H; Anderson LG; Soeldner JS
    N Engl J Med; 1974 Feb; 290(6):344. PubMed ID: 4809290
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potentiation of tolbutamide by phenylbutazone].
    GULBRANDSEN R
    Tidsskr Nor Laegeforen; 1959 Oct; 79():1127-8. PubMed ID: 13830244
    [No Abstract]   [Full Text] [Related]  

  • 8. An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin.
    Welch RM; Harrison YE; Conney AH; Burns JJ
    Clin Pharmacol Ther; 1969; 10(6):817-25. PubMed ID: 4186901
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of feprazone and phenylbutazone interaction with warfarin in man.
    Chierichetti S; Bianchi G; Cerri B
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):568-72. PubMed ID: 810317
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of phenylbutazone, tolbutamide and metabolites in plasma and urine using chemical ionization mass spectrometry.
    Weinkam RJ; Rowland M; Meffin PJ
    Biomed Mass Spectrom; 1977 Feb; 4(1):42-7. PubMed ID: 836942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers].
    Gentile S; Porcellini M; Foglia F; Loguercio C; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):345-8. PubMed ID: 552849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
    Welch RM
    Ann N Y Acad Sci; 1973 Nov; 226():259-66. PubMed ID: 4129139
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 17. Half life of intravenous tolbutamide in the serum of patients in medical wards.
    Sotaniemi EA; Huhti E
    Ann Clin Res; 1974 Jun; 6(3):146-54. PubMed ID: 4844125
    [No Abstract]   [Full Text] [Related]  

  • 18. Competition between diftalone and other drugs for the binding site(s) on human serum albumin.
    Assandri A; Perazzi A
    Med Biol; 1976 Jun; 54(3):187-92. PubMed ID: 940363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the hypoglycaemic action of tolbutamide by different drugs.
    Mahfouz M; Abdel-Maguid R; el-Dakhakhny M
    Arzneimittelforschung; 1970 Jan; 20(1):120-2. PubMed ID: 5467602
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. Enzyme induction and interaction with other drugs in the rat.
    Coppi G; Vidi A; Vanoni PC; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:242-6. PubMed ID: 4111897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.